NCT01393990 2020-03-24A Study of LY2228820 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed89 enrolled 30 charts
NCT01663857 2019-09-11A Study LY2228820 for Recurrent Ovarian CancerEli Lilly and CompanyPhase 1/2 Completed118 enrolled 18 charts